Tag: Breaking

Phase 1 Trial of HCW9302 Marks a Milestone in Autoimmune Disease Research HCW Biologics (HCWB), a clinical-stage biopharmaceutical company specializing ...

Authorities and Tesla Investigate Incident Amid Heightened Security Ttragic and alarming incident unfolded on Wednesday when a Tesla (TSLA) Cybertruck ...

Company Rides Bitcoin Wave to Secure Institutional Validation MicroStrategy (MSTR) the software company turned Bitcoin powerhouse, continues to deepen its ...

Chipmaker Eyes Up to $90 Billion AI Revenue Opportunity by 2027 Broadcom's (AVGO) valuation surged past the $1 trillion mark ...

Private equity firm considers taking the struggling pharmacy giant private amid ongoing challenges Walgreens Boots Alliance (WBA) experienced a dramatic ...

Company reaffirms diversified investment strategy as Bitcoin's corporate adoption grows Microsoft (MSFT) shareholders voted against a proposal to allocate a ...

Despite robust cloud growth, Oracle faces challenges converting AI demand into sustained revenue acceleration Oracle Corporation (ORCL) experienced a significant ...

Favorable safety results pave the way for Phase 1 human trials in early 2025, offering hope for millions seeking non-addictive ...

Acquisition talks could reshape the global chocolate industry Mondelez International (MDLZ), the maker of iconic brands like Cadbury and Oreo, ...

Beijing pledges fiscal and monetary support to stabilize growth and boost domestic consumption China’s leadership has outlined a cautious yet ...